High blood pressure; chest pain; Heart racing; couldn't move off couch; not feeling well; Hard to the touch Injection Site; Vaccination site Bump; arm still presents a little bit of swelling on injection site; little bit of redness on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (Penicillin allergy) and Pollen allergy (Pollen). Concomitant products included CETIRIZINE HYDROCHLORIDE for Allergy.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm still presents a little bit of swelling on injection site) and VACCINATION SITE ERYTHEMA (little bit of redness on the Injection Site). On 08-Feb-2021, the patient experienced VACCINATION SITE MASS (Vaccination site Bump) and VACCINATION SITE INDURATION (Hard to the touch Injection Site). On 10-Feb-2021, the patient experienced HYPERTENSION (High blood pressure) (seriousness criterion hospitalization) and MALAISE (not feeling well). On 12-Feb-2021, the patient experienced PALPITATIONS (Heart racing) and MOBILITY DECREASED (couldn't move off couch). On an unknown date, the patient experienced CHEST PAIN (chest pain). The patient was hospitalized from 14-Feb-2021 to 15-Feb-2021 due to HYPERTENSION. The patient was treated with METOPROLOL SUCCINATE from 11-Feb-2021 to 12-Feb-2021 for Blood pressure high, at a dose of 25 milligram and AMLODIPINE BESILATE (AMLOPINE) ongoing from June 2021 for Blood pressure management, at a dose of 2.5 milligram. At the time of the report, HYPERTENSION (High blood pressure), VACCINATION SITE SWELLING (arm still presents a little bit of swelling on injection site) and VACCINATION SITE ERYTHEMA (little bit of redness on the Injection Site) had not resolved and PALPITATIONS (Heart racing), CHEST PAIN (chest pain), VACCINATION SITE MASS (Vaccination site Bump), MALAISE (not feeling well), MOBILITY DECREASED (couldn't move off couch) and VACCINATION SITE INDURATION (Hard to the touch Injection Site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Blood pressure measurement (117-125): 160-180 (High) 160-180. On 14-Feb-2021, Blood pressure measurement (117-125): >200 (High) over 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 11-Feb-2021, the patient consulted a doctor for high blood pressure and was prescribed metoprolol succinate ER (extended release). She took only one pill. On 14-Feb-2021, she went to the hospital and was admitted till 15-Feb-2021. Various tests were done, including CT scan on lungs. She was recommended to see a cardiologist. Her appointment with the internist was on 12-Mar-2021 and with the cardiologist was on 07-Apr-2021. She was given a prescription for amlopine.  She reported that her blood pressure was still fluctuating above 160-165.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-025495 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow Up information was received on 23-Jun-2021 ADR form updated. Added lab details, medical history, concomitant medication, new events (chest pain, high BP and heart racing), outcome of events, hospitalization details, treatment medications, demographics, race, physician details.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.